Mustang Bio (2W6) Ratios
Mustang Bio Ratios
DE:2W6's free cash flow for Q2 2026 was $-967.00K. For the 2026 fiscal year, DE:2W6's free cash flow was increased by $0.00 and operating cash flow was $-967.00K. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 2.22 | 0.68 | 0.74 | 5.22 | 10.33 |
| Quick Ratio | 2.22 | 0.68 | 0.74 | 5.22 | 10.33 |
| Cash Ratio | 2.18 | 0.54 | 0.41 | 5.01 | 10.14 |
| Solvency Ratio | -0.23 | -1.13 | -2.80 | -1.61 | -5.02 |
| Operating Cash Flow Ratio | -0.67 | -0.90 | -3.22 | -4.31 | -4.96 |
| Short-Term Operating Cash Flow Coverage | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Current Asset Value | $ 9.53M | $ -4.58M | $ -6.27M | $ 32.70M | $ 98.94M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.00 | 0.09 | 0.14 | 0.34 | 0.02 |
| Debt-to-Equity Ratio | 0.00 | -0.23 | 20.31 | 0.68 | 0.02 |
| Debt-to-Capital Ratio | 0.00 | -0.29 | 0.95 | 0.40 | 0.02 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.37 | 0.00 |
| Financial Leverage Ratio | 1.85 | -2.40 | 144.24 | 2.00 | 1.11 |
| Debt Service Coverage Ratio | 0.00 | 2984.80 | -36.58 | -21.18 | -4269.93 |
| Interest Coverage Ratio | 0.00 | 3249.00 | -38.60 | -22.67 | -4448.20 |
| Debt to Market Cap | 0.00 | 0.00 | 0.00 | 0.01 | 0.00 |
| Interest Debt Per Share | 0.00 | 0.14 | 0.44 | 5.04 | 0.35 |
| Net Debt to EBITDA | 9.18 | 0.40 | 0.08 | 0.62 | 1.68 |
| Profitability Margins | |||||
| Gross Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EBIT Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EBITDA Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Operating Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Pretax Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Net Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Continuous Operations Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Net Income Per EBT | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
| EBT Per EBIT | 78.99% | 96.97% | 101.73% | 101.79% | 99.47% |
| Return on Assets (ROA) | -10.92% | -169.23% | -290.85% | -83.88% | -53.02% |
| Return on Equity (ROE) | -20.16% | 406.71% | -41952.85% | -167.54% | -59.05% |
| Return on Capital Employed (ROCE) | -25.13% | 492.12% | -2139.43% | -98.51% | -58.35% |
| Return on Invested Capital (ROIC) | -25.13% | 571.00% | -1754.62% | -97.73% | -58.17% |
| Return on Tangible Assets | -10.92% | -169.23% | -290.85% | -83.88% | -53.02% |
| Earnings Yield | -39.90% | -29.04% | -8.88% | -3.80% | -0.91% |
| Efficiency Ratios | |||||
| Receivables Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Payables Turnover | 0.01 | 0.00 | 0.35 | 0.44 | 0.66 |
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fixed Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Working Capital Turnover Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | -31247.56 | 0.00 | -1037.09 | -822.85 | -555.89 |
| Days of Sales Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Payables Outstanding | 31247.56 | 0.00 | 1037.09 | 822.85 | 555.89 |
| Operating Cycle | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -1.07 | -1.86 | -5.75 | -9.44 | -9.16 |
| Free Cash Flow Per Share | -1.07 | -1.86 | -5.76 | -9.88 | -10.08 |
| Dividend Paid and CapEx Coverage Ratio | 0.00 | -18.67 | -434.01 | -21.13 | -10.00 |
| Capital Expenditure Coverage Ratio | 0.00 | 0.00 | -434.01 | -21.13 | -10.00 |
| Operating Cash Flow Coverage Ratio | 0.00 | -13.00 | -19.81 | -2.07 | -26.40 |
| Operating Cash Flow to Sales Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Free Cash Flow Yield | -109.33% | -21.04% | -8.54% | -3.34% | -0.81% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -2.52 | -3.44 | -11.25 | -26.34 | -109.91 |
| Price-to-Sales (P/S) Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Price-to-Book (P/B) Ratio | 0.51 | -14.00 | 4721.76 | 44.14 | 64.90 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -0.91 | -4.75 | -11.71 | -29.97 | -123.57 |
| Price-to-Operating Cash Flow Ratio | -0.91 | -4.75 | -11.74 | -31.39 | -135.92 |
| Price-to-Earnings Growth (PEG) Ratio | 0.03 | 0.06 | 0.24 | 20.02 | 3.30 |
| Enterprise Value Multiple | 6.62 | -3.23 | -12.01 | -28.09 | -112.21 |
| Enterprise Value | -12.45M | 48.27M | 577.04M | 2.00B | 7.19B |
| EV to EBITDA | 6.62 | -3.23 | -12.01 | -28.09 | -112.21 |
| EV to Sales | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EV to Free Cash Flow | 2.37 | -4.23 | -11.64 | -29.32 | -121.74 |
| EV to Operating Cash Flow | 2.37 | -4.23 | -11.66 | -30.71 | -133.92 |
| Tangible Book Value Per Share | 1.94 | -0.63 | 0.01 | 6.71 | 19.18 |
| Shareholders’ Equity Per Share | 1.94 | -0.63 | 0.01 | 6.71 | 19.18 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Revenue Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income Per Share | -0.39 | -2.57 | -6.00 | -11.24 | -11.33 |
| Tax Burden | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Interest Burden | 1.00 | 1.00 | 1.03 | 1.05 | 1.00 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 2.74 | 0.72 | 0.96 | 0.84 | 0.81 |
Currency in USD